Document is current
Any future updates will be listed below
-
Authors
Schworer, Emily K. https://orcid.org/0000-0002-5309-339X
Esbensen, Anna J.
Nguyen, Vivian
Bullard, Lauren
Fidler, Deborah J.
Daunhauer, Lisa A.
Mervis, Carolyn B.
Becerra, Angela M.
Abbeduto, Leonard
Thurman, Angela John
-
Funding
Funding for this research was provided by:
eunice kennedy shriver national institute of child health and human development (R01HD093654, P50HD103526)
national institutes of health (UL1TR000002)
- License Information
-
More Information
Article History
Received: 29 June 2021
Accepted: 23 February 2022
First Online: 12 March 2022
Declarations
:
: Institutional Review Boards at the University of California Davis, Cincinnati Children’s Hospital Medical Center, Colorado State University, and University of Louisville approved all study procedures. Caregivers of child participants provided consent. The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and international committees on human experimentation.
: Not applicable
: LA has received funding from F. Hoffmann-La Roche Ltd., Roche TCRC, Inc., Neuren Pharmaceuticals Ltd., Fulcrum Therapeutics, and Lumind to consult on and implement outcome measures in clinical trials for FXS and DS. AJT has received funding from Fulcrum Therapeutics to develop outcome measures for FXS. The other authors declare that they have no competing interests.
